Rankings
▼
Calendar
MNKD Q2 2023 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$813M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$49M
+157.3% YoY
Gross Profit
$34M
70.7% margin
Operating Income
$2M
3.5% margin
Net Income
-$5M
-10.8% margin
EPS (Diluted)
$-0.02
QoQ Revenue Growth
+19.7%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
-$14M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$313M
Total Liabilities
$574M
Stockholders' Equity
-$260M
Cash & Equivalents
$86M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$49M
$19M
+157.3%
Gross Profit
$34M
$6M
+474.9%
Operating Income
$2M
-$20M
+108.4%
Net Income
-$5M
-$29M
+81.9%
Revenue Segments
License and Service
$9M
100%
← FY 2023
All Quarters
Q3 2023 →